RecruitingNCT06038409

Ketamine Treatment Plans for Chronic Conditions

Understanding the Safety of Home Ketamine Treatment Plans for Chronic Conditions


Sponsor

RIVER Foundation

Enrollment

500 participants

Start Date

Jan 1, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

A study aimed to assess the efficacy of the various approaches to prescribing Ketamine currently in use off-label. The focus will be to include ketamine within the study plan of those with chronic conditions who are receiving ketamine.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is examining how ketamine — a medication already used in clinical settings — can be used to treat pain and other symptoms in people with chronic (long-term) health conditions. **You may be eligible if...** - You have a chronic (ongoing) health condition that causes persistent symptoms such as pain **You may NOT be eligible if...** - You are generally healthy with no chronic conditions Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGKetamine

The efficacy of the various approaches to prescribing Ketamine currently in use off-label. The focus will be to include ketamine within the treatment plan of those with chronic conditions


Locations(1)

RIVER Telehealth

Helena, Montana, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06038409


Related Trials